PharmChem, Inc.
PCHM
$3.40
$0.0270.80%
OTC PK
| 09/30/2003 | 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | |
|---|---|---|---|---|---|
| Revenue | -5.11% | -11.80% | -15.26% | -10.53% | -25.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.11% | -11.80% | -15.26% | -10.53% | -25.53% |
| Cost of Revenue | -8.84% | -11.27% | -9.58% | -50.75% | -21.04% |
| Gross Profit | 9.04% | -13.65% | -33.08% | 171.28% | -38.74% |
| SG&A Expenses | -9.53% | 2.64% | -10.68% | -55.16% | -10.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.03% | -7.98% | -9.87% | -52.01% | -18.59% |
| Operating Income | 52.02% | -257.76% | -186.83% | 103.13% | -3,805.56% |
| Income Before Tax | 130.18% | -184.62% | -86.99% | 105.63% | 57.87% |
| Income Tax Expenses | -- | -- | -- | 100.00% | -- |
| Earnings from Continuing Operations | 130.18% | -166.83% | -136.45% | 105.95% | 56.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -100.00% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 130.18% | -166.83% | -116.94% | 108.96% | 50.66% |
| EBIT | 52.02% | -257.76% | -186.83% | 103.13% | -3,805.56% |
| EBITDA | 283.33% | -75.05% | -108.36% | 112.59% | -120.69% |
| EPS Basic | 130.14% | -167.04% | -116.94% | 108.98% | 50.65% |
| Normalized Basic EPS | 49.60% | -185.10% | -86.87% | 100.72% | -747.12% |
| EPS Diluted | 128.37% | -137.00% | -117.59% | 108.98% | 51.06% |
| Normalized Diluted EPS | 50.17% | -185.10% | -86.87% | 100.72% | -747.12% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 1.20% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |